Quantcast
Tag archive for ‘melanoma’
By The Dispatch On Sunday, June 18th, 2017
1 Comment

Melanoma: Radon increases risk for malignant skin cancer according to Swiss researchers

It is undisputed that radon is a risk factor for developing lung cancer. New research by the Swiss Tropical and Public Health Institute (Swiss TPH) in the context of the Swiss National Cohort study now shows that More...

By The Dispatch On Monday, December 22nd, 2014
0 Comments

Melanoma drug, Opdivo, gets FDA approval

The U.S. Food and Drug Administration today granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who More...

By The Dispatch On Tuesday, May 27th, 2014
1 Comment

Dermatology group release PSA about skin cancer in older men

PRESS RELEASE SCHAUMBURG, Ill. (May 27, 2014) –  The American Academy of Dermatology (Academy) today launched “Lawn,” a public service advertisement (PSA) that encourages older men to check their skin for More...

By The Dispatch On Thursday, May 1st, 2014
0 Comments

Melanoma/Skin Cancer Detection and Prevention Month: How to Spot Skin Cancer

PRESS RELEASE SCHAUMBURG, Ill. (May 1, 2014) – It is estimated that one in five Americans will be diagnosed with skin cancer in the course of their lifetime, and one person dies from melanoma – the deadliest More...

By Robert Herriman On Friday, January 10th, 2014
2 Comments

FDA approves Mekinist in combination with Tafinlar for advanced melanoma

PRESS RELEASE This week the U.S. Food and Drug Administration approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (cannot be removed More...


Recent Posts

December 6, 2019, Comments Off on

December 6, 2019, Comments Off on

December 4, 2019, Comments Off on

DISPATCH BLOGS

Splash Page logo 300x146 Today in History